Literature DB >> 19247375

miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis.

Christoph A Gebeshuber1, Kurt Zatloukal, Javier Martinez.   

Abstract

Several microRNAs (miRNAs) have recently been described as crucial regulators of epithelial-to-mesenchymal transition (EMT) and metastasis. By comparing the expression profiles of miRNAs, we found upregulation of miR-29a in mesenchymal, metastatic RasXT cells relative to epithelial EpRas cells. Overexpression of miR-29a suppressed the expression of tristetraprolin (TTP), a protein involved in the degradation of messenger RNAs with AU-rich 3'-untranslated regions, and led to EMT and metastasis in cooperation with oncogenic Ras signalling. We also observed enhanced miR-29a and reduced TTP levels in breast cancer patient samples, indicating relevance for human disease. Previously, miR-29 family members were shown to have tumour-suppressive effects in haematopoietic, cholangiocytic and lung tumours. Therefore, miRNAs can act as either oncogenes or tumour suppressors, depending on the context.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19247375      PMCID: PMC2672883          DOI: 10.1038/embor.2009.9

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  27 in total

1.  Expression profiling of epithelial plasticity in tumor progression.

Authors:  Martin Jechlinger; Stefan Grunert; Ido H Tamir; Elzbieta Janda; Susanna Lüdemann; Thomas Waerner; Peter Seither; Andreas Weith; Hartmut Beug; Norbert Kraut
Journal:  Oncogene       Date:  2003-10-16       Impact factor: 9.867

Review 2.  Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis.

Authors:  Stefan Grünert; Martin Jechlinger; Hartmut Beug
Journal:  Nat Rev Mol Cell Biol       Date:  2003-08       Impact factor: 94.444

3.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

4.  Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element.

Authors:  Edward Hitti; Tatiana Iakovleva; Matthew Brook; Stefanie Deppenmeier; Achim D Gruber; Danuta Radzioch; Andrew R Clark; Perry J Blackshear; Alexey Kotlyarov; Matthias Gaestel
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

5.  Involvement of microRNA in AU-rich element-mediated mRNA instability.

Authors:  Qing Jing; Shuang Huang; Sabine Guth; Tyler Zarubin; Andrea Motoyama; Jianming Chen; Franco Di Padova; Sheng-Cai Lin; Hermann Gram; Jiahuai Han
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

6.  A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA.

Authors:  Georg Stoecklin; Brigitte Gross; Xiu-Fen Ming; Christoph Moroni
Journal:  Oncogene       Date:  2003-06-05       Impact factor: 9.867

Review 7.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

8.  The role of mRNA turnover in the regulation of tristetraprolin expression: evidence for an extracellular signal-regulated kinase-specific, AU-rich element-dependent, autoregulatory pathway.

Authors:  Seth A Brooks; John E Connolly; William F C Rigby
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

9.  A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency.

Authors:  G A Taylor; E Carballo; D M Lee; W S Lai; M J Thompson; D D Patel; D I Schenkman; G S Gilkeson; H E Broxmeyer; B F Haynes; P J Blackshear
Journal:  Immunity       Date:  1996-05       Impact factor: 31.745

10.  Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways.

Authors:  Elzbieta Janda; Kerstin Lehmann; Iris Killisch; Martin Jechlinger; Michaela Herzig; Julian Downward; Hartmut Beug; Stefan Grünert
Journal:  J Cell Biol       Date:  2002-01-14       Impact factor: 10.539

View more
  175 in total

Review 1.  Micro-RNAs and breast cancer.

Authors:  John Le Quesne; Carlos Caldas
Journal:  Mol Oncol       Date:  2010-04-28       Impact factor: 6.603

Review 2.  The roles of TTP and BRF proteins in regulated mRNA decay.

Authors:  Sandhya Sanduja; Fernando F Blanco; Dan A Dixon
Journal:  Wiley Interdiscip Rev RNA       Date:  2011 Jan-Feb       Impact factor: 9.957

Review 3.  Shielding the messenger (RNA): microRNA-based anticancer therapies.

Authors:  Elena Sotillo; Andrei Thomas-Tikhonenko
Journal:  Pharmacol Ther       Date:  2011-04-14       Impact factor: 12.310

Review 4.  The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury.

Authors:  Alison J Kriegel; Yong Liu; Yi Fang; Xiaoqiang Ding; Mingyu Liang
Journal:  Physiol Genomics       Date:  2012-01-03       Impact factor: 3.107

5.  Follicle-stimulating hormone regulation of microRNA expression on progesterone production in cultured rat granulosa cells.

Authors:  Nan Yao; Bai-Qing Yang; Yu Liu; Xin-Yu Tan; Cai-Ling Lu; Xiao-Hua Yuan; Xu Ma
Journal:  Endocrine       Date:  2010-08-24       Impact factor: 3.633

Review 6.  microRNAs and EMT in mammary cells and breast cancer.

Authors:  Josephine A Wright; Jennifer K Richer; Gregory J Goodall
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-25       Impact factor: 2.673

Review 7.  Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes.

Authors:  Sasagu Kurozumi; Yuri Yamaguchi; Masafumi Kurosumi; Miki Ohira; Hiroshi Matsumoto; Jun Horiguchi
Journal:  J Hum Genet       Date:  2016-07-21       Impact factor: 3.172

8.  MiR-29 silencing modulates the expression of target genes related to proliferation, apoptosis and methylation in Burkitt lymphoma cells.

Authors:  Luciano Mazzoccoli; Marcela Cristina Robaina; Alexandre Gustavo Apa; Martin Bonamino; Luciana Wernersbach Pinto; Eduardo Queiroga; Carlos E Bacchi; Claudete Esteves Klumb
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-09       Impact factor: 4.553

9.  Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.

Authors:  Andrew L Feldman; Ahmet Dogan; David I Smith; Mark E Law; Stephen M Ansell; Sarah H Johnson; Julie C Porcher; Nazan Ozsan; Eric D Wieben; Bruce W Eckloff; George Vasmatzis
Journal:  Blood       Date:  2010-10-28       Impact factor: 22.113

Review 10.  Epithelial to mesenchymal transition and breast cancer.

Authors:  Eva Tomaskovic-Crook; Erik W Thompson; Jean Paul Thiery
Journal:  Breast Cancer Res       Date:  2009-11-09       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.